I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Symmans, William F.
90
results:
Search for persons
X
Format
Online (90)
Mediatypes
Articles (Online) (64)
OpenAccess-fulltext (26)
Sorted by: Year
Sorted by: Relevance
?
1
Neoadjuvant talazoparib in patients with germline BRCA1/2 m..:
Telli, Melinda L.
;
Litton, Jennifer K.
;
Beck, J. Thaddeus
...
Breast Cancer. , 2024
Link:
https://doi.org/10.1007/..
?
2
Adjuvant platinum versus capecitabine for residual, invasiv..:
Smith, Karen L.
;
Zhao, Fengmin
;
Mayer, Ingrid A.
...
Cancer. , 2024
Link:
https://doi.org/10.1002/..
?
3
Neoadjuvant Talazoparib in Patients With Germline BRCA1/2 M..:
Litton, Jennifer K
;
Beck, J Thaddeus
;
Jones, Jason M
...
The Oncologist. , 2023
Link:
https://doi.org/10.1093/..
?
4
Dysregulation and Epigenetic Reprogramming of NRF2 Signalin..:
Osman, Abdullah A.
;
Arslan, Emre
;
Bartels, Mason
...
Clinical Cancer Research. 29 (2023) 7 - p. 1344-1359 , 2023
Link:
https://doi.org/10.1158/..
?
5
Endocrine therapy synergizes with SMAC mimetics to potentia..:
Hermida-Prado, Francisco
;
Xie, Yingtian
;
Sherman, Shira
...
Cancer Research. , 2023
Link:
https://doi.org/10.1158/..
?
6
Protein signaling and drug target activation signatures to ..:
Gallagher, Rosa I.
;
Wulfkuhle, Julia
;
Wolf, Denise M.
...
Cell Reports Medicine. 4 (2023) 12 - p. 101312 , 2023
Link:
https://doi.org/10.1016/..
?
7
PTEN in triple-negative breast carcinoma: protein expressio..:
Chen, Hui
;
Ding, Qingqing
;
Khazai, Laila
...
Therapeutic Advances in Medical Oncology. 15 (2023) - p. , 2023
Link:
https://doi.org/10.1177/..
?
8
Predictive Roles of Baseline Stromal Tumor-Infiltrating Lym..:
Abuhadra, Nour
;
Sun, Ryan
;
Yam, Clinton
...
Cancers. 15 (2023) 13 - p. 3275 , 2023
Link:
https://doi.org/10.3390/..
?
9
Immunological and clinicopathological features predict HER2..:
Rediti, Mattia
;
Fernandez-Martinez, Aranzazu
;
Venet, David
...
Nature Communications. 14 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
10
Assessment of stained direct cytology smears of breast canc..:
Marczyk, Michal
;
Fu, Chunxiao
;
Lau, Rosanna
...
Cancer Cytopathology. 131 (2023) 5 - p. 289-299 , 2023
Link:
https://doi.org/10.1002/..
?
11
Gene signatures derived from transcriptomic-causal networks..:
Yazdani, Akram
;
Lenz, Heinz-Josef
;
Pillonetto, Gianluigi
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10760223/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
12
Endocrine Therapy Synergizes with SMAC Mimetics to Potentia..:
Hermida-Prado, Francisco
;
Xie, Yingtian
;
Sherman, Shira
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10543960/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
13
Evaluation of the Sensitivity to Endocrine Therapy Index an..:
Speers, Corey W
;
Symmans, W. Fraser
;
Barlow, William E
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082279/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
14
Dysregulation and Epigenetic Reprogramming of NRF2 Signalin..:
Osman, Abdullah A
;
Arslan, Emre
;
Bartels, Mason
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068451/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
15
Long-term efficacy and safety of addition of carboplatin wi..:
Geyer, C.E.
;
Sikov, W.M.
;
Huober, J.
...
Annals of Oncology. 33 (2022) 4 - p. 384-394 , 2022
Link:
https://doi.org/10.1016/..
1-15